Colgate-Palmolive: 3 Key Takeaways for Long-Term Investors

Colgate-Palmolive reported strong organic sales growth across its five divisions during its Q3 2026 earnings call on October 30, 2026. CEO Noel Wallace highlighted three key takeaways: pricing power, cost reduction, and innovation.

Firstly, Colgate-Palmolive is leveraging its pricing power to shield its operating margins from rising input costs. The company is rapidly incorporating price increases into its financial statements to protect profitability. Wallace stated, "Clearly, we are getting pricing into the P&L as quickly as we can."

Secondly, the company's internal cost-reduction programs are generating significant savings, with the Funding-the-Growth initiative providing structural relief. Stan Sutula, CFO, explained, "Funding-the-growth drove over 290 basis points of offset to the material inflation, and that is really the hard work of all of the Colgate people around the world driving that performance."

Thirdly, focused innovation in high-margin categories, particularly in Hill's Pet Nutrition segment, is expanding sales. Wallace noted, "Most of that growth is the strategic focus we have on growing segments, particularly cat and wet, and market share growth." The company's commitment to science-based products and operational advantages, such as revenue growth management (RGM) and artificial intelligence (AI) tools, positions it well in emerging markets, despite increased competition.

Overall, Colgate-Palmolive's global momentum remains solid, and the company is optimistic about its long-term success despite uncertainties. CEO Wallace concluded, "We believe our efforts in RGM, AI, and our funding-the-growth initiatives give us the flexibility needed to invest appropriately in advertising to build our brands while driving profit and compounding EPS growth, even in a period of significant cost inflation."